Form 8-K - Current report:
SEC Accession No. 0001680367-24-000050
Filing Date
2024-11-14
Accepted
2024-11-14 07:04:03
Documents
15
Period of Report
2024-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sttk-20241114.htm   iXBRL 8-K 29257
2 EX-99.1 sttk_q32024earningsrelease.htm EX-99.1 78340
6 image_2a.jpg GRAPHIC 10600
  Complete submission text file 0001680367-24-000050.txt   261925

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sttk-20241114.xsd EX-101.SCH 1797
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sttk-20241114_lab.xml EX-101.LAB 23449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sttk-20241114_pre.xml EX-101.PRE 13591
17 EXTRACTED XBRL INSTANCE DOCUMENT sttk-20241114_htm.xml XML 2911
Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Filer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39593 | Film No.: 241457127
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)